Zomedica Corp. (NASDAQ:ZOM)

PRESS RELEASE

published on 02/26/2025 at 12:30, 1 year ago

Zomedica to Report Fourth Quarter and Full Year 2024 Financial Results with a Business Update on March 13th at 4:30 p.m. ET
Zomedica Corp. to host conference call on March 13, 2025, to discuss Q4 and FY 2024 financial results. Leading veterinary health company offering innovative solutions

Financial Results Conference Call Innovative Solutions Zomedica Corp. Veterinary Health
BRIEF

published on 02/12/2025 at 12:35, 1 year 1 month ago

Zomedica déménage son siège social pour accroître son efficacité et réduire ses coûts

Stratégie De Croissance Zomedica Économies De Coûts Efficacité Déménagement
BRIEF

published on 02/12/2025 at 12:35, 1 year 1 month ago

Zomedica Relocates Headquarters to Boost Efficiency and Cut Costs

Growth Strategy Zomedica Efficiency Cost Savings Relocation
PRESS RELEASE

published on 02/12/2025 at 12:30, 1 year 1 month ago

Zomedica Improves Efficiency and Cuts Costs by Moving to New Headquarters
Zomedica Corp. relocates headquarters to a more efficient space in Ann Arbor, MI, reducing overhead costs by over $200,000 annually. The move supports growth and operational efficiency

Zomedica Corp. Efficiency Growth Cost-saving Relocation
BRIEF

published on 02/06/2025 at 12:35, 1 year 1 month ago

Zomedica améliore le test TRUFORMA pour un meilleur diagnostic du PPID équin

Zomedica TRUFORME PPID Diagnostic Équin Dosage De L'ACTH
BRIEF

published on 02/06/2025 at 12:35, 1 year 1 month ago

Zomedica Enhances TRUFORMA Assay for Improved Equine PPID Diagnosis

Zomedica TRUFORMA Equine Diagnostics ACTH Assay PPID
PRESS RELEASE

published on 02/06/2025 at 12:30, 1 year 1 month ago

Zomedica Launches the TRUFORMA(R) Enhanced Endogenous ACTH Assay to aid in Equine PPID Diagnosis
Zomedica announces groundbreaking update to the TRUFORMA biosensor platform with enhancements to the eACTH assay for equine plasma, providing valuable insights into Pituitary Pars Intermedia Dysfunction (PPID) diagnosis

Zomedica TRUFORMA Biosensor Technology EACTH Assay PPID Diagnosis
BRIEF

published on 01/07/2025 at 12:35, 1 year 2 months ago

Zomedica Secures License Agreement with Cresilon Inc. for Vetigel® Distribution

Veterinary Care Zomedica Vetigel® Cresilon Hemostatic Gel
BRIEF

published on 01/07/2025 at 12:35, 1 year 2 months ago

Zomedica conclut un accord de licence avec Cresilon Inc. pour la distribution de Vetigel®

Zomedica Soins Vétérinaires Vetigel® Cresilon Gel Hémostatique
PRESS RELEASE

published on 01/07/2025 at 12:30, 1 year 2 months ago

Zomedica Announces License & Supply Agreement with Cresilon Inc. to Market and Sell Vetigel(R) Hemostatic Gel in the Animal Health Market
Zomedica Corp. partners with Cresilon, expanding portfolio with groundbreaking Vetigel® hemostatic gel to enhance veterinary care and surgical efficiency worldwide

Veterinary Care Zomedica Vetigel® Cresilon Hemostatic Gel

Published on 03/23/2026 at 08:00, 1 hour 55 minutes ago

ABRIDGED, PRELIMINARY AND UNAUDITED QUARTERLY AND FULL YEAR RESULTS AND DETAILS OF MANAGEMENT CONFERENCE Call for the Fourth Quarter and Full Year Ended December 31, 2025 ("The Quarter" or "Q4 2025" and "FY 2025" Respectively)
Published on 03/23/2026 at 02:00, 7 hours 55 minutes ago

FutureGen Industries Announces Open Market Investments
Published on 03/20/2026 at 23:00, 2 days 10 hours ago

Cypher Announces Private Placement
Published on 03/20/2026 at 21:30, 2 days 12 hours ago

Sky Gold Sets Options
Published on 03/20/2026 at 21:15, 2 days 12 hours ago

Earthwise Minerals Announces Private Placement

View all ACCESSWIRE

Published on 03/23/2026 at 09:19, 36 minutes ago

Mister Spex Chooses Salesforce to further develop its Omnichannel Strategy
Published on 03/23/2026 at 09:00, 54 minutes ago

Removal: Tower Bridge Funding 2022-1 PLC
Published on 03/23/2026 at 09:00, 54 minutes ago

Removal: Imara Gold plc
Published on 03/23/2026 at 09:00, 54 minutes ago

Official List Notice
Published on 03/23/2026 at 09:00, 54 minutes ago

EQS Group launches Risk Management module to support continuous data and AI risk oversight

View all EQS

Published on 03/23/2026 at 08:10, 1 hour 45 minutes ago

Entrée en négociations exclusives de cession de la participation dans Winncare
Published on 03/20/2026 at 19:00, 2 days 14 hours ago

AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 14 hours ago

AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 15 hours ago

Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 15 hours ago

Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA

View all LES ECHOS COMFI WIRE

News